Privia Health Group, Inc. (PRVA) Q4 FY25 Earnings Call

Strong provider and value-based growth supports roughly 20% EBITDA growth, while taxes and slower collections temper 2026 cash conversion.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-02
Length63 minutes
EPS$0.07
EPS consensus$0.04
Revenue$580.4M
Revenue consensus$516.6M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All PRVA earnings ยท Back to PRVA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.